Related Experiment Video
Updated: Sep 3, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
A Case of Elevated Troponin I Level After Packed Red Blood Cell Transfusion With Normal Coronary Angiography
Sherif Roman1, Manpreet Sran2, Amgad N Makaryus3,4
1Internal Medicine, St. Joseph's Regional Medical Center, Paterson, USA.
Insights
Elevated cardiac troponin I (cTnI) levels can occur in conditions beyond acute coronary syndrome (ACS). This case highlights post-transfusion interference as a cause of falsely high cTnI, mimicking ACS.
Area of Science:
- Clinical Biochemistry
- Cardiology
- Laboratory Medicine
Background:
- Elevated cardiac troponin I (cTnI) levels are a key biomarker for acute coronary syndrome (ACS).
- However, numerous non-ACS clinical conditions, including pulmonary embolism, heart failure, myocarditis, sepsis, and renal failure, can also elevate cTnI.
- Analytical interferences, such as fibrin clots, heterophile antibodies, and hemolysis, can lead to falsely elevated cTnI results.
Observation:
- A 66-year-old female presented with pleuritic chest pain.
- Following transfusion of three units of packed red blood cells, her cTnI level was measured at 35.5 ng/mL.
- A comprehensive evaluation for ACS, including coronary angiography, was negative for obstructive coronary artery disease.
Findings:
- The elevated cTnI level in this patient was not attributable to acute coronary syndrome.
- Post-transfusion laboratory interference is a potential cause of elevated cTnI, mimicking cardiac ischemia.
- This case underscores the importance of considering analytical interferences in the interpretation of cTnI results.
Implications:
- Clinicians should consider non-ischemic causes and analytical interferences when interpreting elevated cTnI levels, especially in the post-transfusion setting.
- Careful patient history and sample assessment are crucial to avoid misdiagnosis of ACS.
- Further investigation into transfusion-related interferences with cTnI assays may be warranted.
Abstract:
Other than acute coronary syndrome (ACS), many clinical conditions are associated with increased cardiac troponin I (cTnI) levels. Conditions such as pulmonary embolism, acute heart failure, myocarditis, sepsis, and renal failure are commonly reported as underlying causes. Analytical interference with the cTnI assay can also lead to falsely elevated troponin I levels. That can happen due to multiple causes such as fibrin clots, heterophile antibodies, microparticles contained in the sample, rheumatoid factor, interference by bilirubin, hemolysis, and elevated alkaline phosphatase activity. Herein, we present the case of a 66-year-old female who presented with pleuritic chest pain and had a cTnI of 35.5 ng/mL post-transfusion of three units of packed red blood cells. The patient had a complete ischemic workup for ACS, including coronary angiography, which was negative for coronary artery disease.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
10:01Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome IV: Interprofessional Care